Chuen Yan Leung joined EQT Partners as an Associate in May 2020.
Prior to joining EQT Partners, Chuen Yan was at Aeneas Capital as a vice president in life science investments in Hong Kong. Before that, he was lead scientist at Procella therapeutics and a postdoctoral researcher at Karolinska Institutet.
Chuen Yan holds a PhD in Embryology & Stem cells from the University of Cambridge and a BSc in Biochemistry from Imperial College.